Takeda’s Revestive becomes first approved drug in Europe for short bowel syndrome
Can reduce dependency on intravenous feeding
Read More
Section: Sales
FDA panel backs Novartis’ updated cystic fibrosis drug
New version of inhaled tobramycin therapy is simpler to use
Read More
US drug approval numbers fall despite pharma investing more in R&D
Stricter FDA policies are partly to blame for the decline says GBI Research
Read MorePfizer gets US approval for leukaemia drug Bosulif
FDA grants the tyrosine kinase inhibitor a licence to treat chronic myelogenous leukaemia
Read More
IFPMA launches expanded code of practice
Clarifies guidelines on continuing medical education and gifts for doctors
Read More